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OPINION OF THE COURT 
 
ALITO, Circuit Judge: 
 
An English pharmaceutical company is fighting to keep 
its lawsuit located in the United States. Its American 
insurance company opponent counters that proper location 
for the lawsuit is England, not the United States. The 
English company, John Wyeth and Brother Limited 
("Wyeth"), sued its American insurer, CIGNA International 
Corporation ("CIGNA"), in federal district court in 
Pennsylvania, seeking an adjudication of its rights under 
certain policies relating to product liability claims in the 
courts of the United Kingdom and the Republic of Ireland. 
The district court granted summary judgment for CIGNA, 
holding that a forum selection clause in a 1990 contract 
between the parties vested exclusive jurisdiction in the 
courts of England. Wyeth appealed, but we affirm. 
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I. 
 
Wyeth manufactures and supplies pharmaceuticals in 
the United Kingdom and Ireland. Since 1987, Wyeth has 
defended itself in the courts of those countries against more 
than 11,000 product liability claims that relate to its 
manufacture and sale of benzodiazepine products. Most of 
the claims concerned Ativan, a tranquilizer that allegedly 
caused dependency and a number of other deleterious side- 
effects. Other claims were based on Wyeth's manufacture 
and sale of Normison and Loramet, which were prescribed 
as hypnotics or sleeping pills. 
 
Wyeth had different primary insurance coverage for three 
different time periods. First, for product liability claims 
from November 1, 1972 through October 31, 1977, Wyeth 
had local insurance coverage in the United Kingdom and 
Ireland through Guardian Royal Exchange Assurance, 
Limited ("GRE") for indemnification and the payment of 
defense costs. Second, for product liability claims in 
connection with products manufactured and distributed in 
the U.K. from November 1, 1977 through October 31, 1980, 
Wyeth had coverage under three occurrence-based 
insurance policies issued by CIGNA's predecessor, the 
American Foreign Insurance Association ("AFIA").1 These 
policies provided coverage for Wyeth's parent corporation, 
the American Home Products Corporation ("AHPC"), a New 
Jersey-based entity, and its U.K. subsidiaries, including 
Wyeth. Third, for occurrences after November 1980, Wyeth 
relied on self-insurance. 
 
Wyeth asserts that, although CIGNA and GRE were 
obligated to pay defense costs relating to claims covered by 
their policies, as of July 1989, both companies had refused 
to advance such payments "on the basis, inter alia, that 
they had not yet determined which policies were triggered 
by which claims in the underlying litigation." (Appellant's 
Br. at 11). Accordingly, Wyeth and its parent, AHPC, 
allegedly proposed that, as an interim measure, CIGNA and 
GRE each pay one-third of these costs and that Wyeth pay 
the remaining one-third. On January 11, 1990, AHPC, 
Wyeth, CIGNA, and other parties entered into an agreement 
_________________________________________________________________ 
 
1. CIGNA acquired AFIA in 1984. 
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(the "1990 Agreement") to "allocat[e] the responsibility for 
Defense costs with respect to Ativan-related injury claims 
for the life of the Agreement." (App. 52). The 1990 
Agreement stated that the parties had been unable to agree 
as to which of the insurance policies applied to the 
individual product liability claims and that "the parties 
intend[ed] to adopt [the 1990 Agreement] by way of 
compromise and accord, and without prejudice to or waiver 
of their respective positions." (App. 52). Under the 1990 
Agreement, CIGNA agreed "to pay [thirty three and one 
third percent] . . . of defense costs incurred to date and 
hereafter during the term of the Agreement." (App. 54). 
Either party had the right to terminate the agreement after 
giving 90 days notice. The 1990 Agreement contained a 
"Reservation of Rights" clause which stated that: 
 
The payment of thirty three and one third percent of 
Defense costs pursuant to this Agreement does not 
constitute evidence of, or an admission by either party 
regarding, the appropriate apportioning of Defense 
costs of the Carriers under the policies issued to the 
Insured Companies. 
 
(App. 55). Most important for purposes of this appeal, the 
1990 Agreement contained a forum selection clause, which 
provided: 
 
This Agreement shall be governed by and construed in 
accordance with English law, and the English Courts 
shall have exclusive jurisdiction in relation to any 





As of January 11, 1990, defense cost obligations for 
claims arising during the period from November 1, 1972, 
through October 31, 1977, were the responsibility of GRE. 
In late 1990, however, GRE exercised its contractual right 
to tender the aggregate amount of the limits of its coverage. 
This tender terminated GRE's responsibilities with respect 
to Wyeth's defense of the benzodiazepine litigation. 
 
Wyeth states that the GRE tender implicated, for thefirst 
time, five AFIA insurance policies covering the 1972-77 
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policy years. These policies allegedly provided Wyeth with 
excess coverage over and above other insurance coverage 
Wyeth may have possessed. Hence, according to Wyeth, 
once GRE tendered the limits of its claims, Wyeth had, for 
the first time, a claim against CIGNA under the 1972-77 
policies for costs incurred after October 5, 1990. CIGNA, 
however, refused to pay Wyeth's costs to the extent they 
exceeded the amount that CIGNA had agreed to pay 
pursuant to the Agreement. CIGNA contends that Wyeth 
sought retrospectively to reallocate past defense costs that 
had been settled at 33.33% and to increase CIGNA's share 
to more than 60%.2 
 
In September 1995, Wyeth brought suit against CIGNA in 
the Eastern District of Pennsylvania. The Complaint sought 
a declaratory judgment that CIGNA was required to pay 
"any and all unreimbursed defense costs incurred by 
[Wyeth] in the defense of the benzodiazepine litigation, to 
the extent such defense costs concern claims occurring 
during the period from November 1, 1972 through October 
31, 1980." (App. 18). In addition, the Complaint sought an 
award of damages. Given that the Complaint asserted that 
CIGNA had "refused to pay [Wyeth's] costs of defending the 
benzodiazepine litigation to the extent such costs .. . 
exceeded the amount of the payments made by [CIGNA] to 
[Wyeth] pursuant to the [1990] Agreement," CIGNA 
countered that the district court lacked jurisdiction over the 
suit due to the foru 
